| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.45 | 0.009 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |